Public Profile

Elanco US, Inc.

Elanco US, Inc., a leading global animal health company, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. The company offers a diverse range of products and services, including vaccines, parasiticides, and nutritional supplements, all designed to enhance animal health and productivity. Elanco's commitment to research and development has led to significant advancements in animal care, positioning it as a trusted partner for veterinarians and farmers alike. With a strong market presence and a reputation for quality, Elanco continues to achieve notable milestones, reinforcing its status as a pioneer in the animal health sector.

DitchCarbon Score

How does Elanco US, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Elanco US, Inc.'s score of 32 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Elanco US, Inc.'s reported carbon emissions

Elanco US, Inc. currently does not have publicly available carbon emissions data or specific reduction targets outlined in their climate commitments. Without emissions figures, it is challenging to assess their performance in terms of Scope 1, 2, or 3 emissions. However, the company is expected to engage in industry-standard climate initiatives, which may include setting future reduction targets and participating in climate pledges. As the landscape of corporate sustainability evolves, Elanco's commitment to addressing climate change will likely become clearer through forthcoming disclosures and initiatives.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Elanco US, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Elanco US, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Elanco US, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adm

US
Food products nec
Updated 2 days ago

Idexx Laboratories

US
Research and development services (73)
Updated 2 days ago

Zoetis

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

MSD Animal Health

GB
Chemicals nec
Updated 3 days ago

Boehringer Ingelheim International GmbH

DE
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Southeastern Minerals, Inc.

US
Animal products nec
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers